Clark Estates Inc. NY Sells 40,123 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Clark Estates Inc. NY reduced its stake in Definitive Healthcare Corp. (NASDAQ:DH) by 10.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 331,127 shares of the company’s stock after selling 40,123 shares during the period. Clark Estates Inc. NY owned approximately 0.29% of Definitive Healthcare worth $1,361,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. Massachusetts Financial Services Co. MA increased its holdings in Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after buying an additional 1,626,813 shares during the period. 272 Capital LP increased its stake in Definitive Healthcare by 74.8% in the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock valued at $4,980,000 after acquiring an additional 476,766 shares during the last quarter. State Street Corp increased its stake in Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock valued at $6,257,000 after acquiring an additional 317,952 shares during the last quarter. JPMorgan Chase & Co. raised its position in Definitive Healthcare by 431.7% during the third quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company’s stock valued at $993,000 after purchasing an additional 180,323 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in Definitive Healthcare during the third quarter worth $512,000. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Stock Down 1.8 %

NASDAQ:DH opened at $2.78 on Wednesday. Definitive Healthcare Corp. has a one year low of $2.58 and a one year high of $8.82. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The company has a market cap of $321.15 million, a PE ratio of -0.90, a P/E/G ratio of 4.06 and a beta of 1.45. The firm’s 50 day simple moving average is $4.58 and its 200 day simple moving average is $4.47.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.04). The business had revenue of $62.29 million during the quarter, compared to the consensus estimate of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. On average, research analysts anticipate that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on DH shares. Stephens initiated coverage on Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. The Goldman Sachs Group lowered their target price on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating for the company in a research note on Tuesday. Finally, Barclays reduced their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research note on Monday. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $5.35.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.